Percutaneous coronary intervention with drug-eluting stents for chronic total occlusion is associated with a 40% rate of binary in-stent restenosis at 8 months
Of patients who receive a drug eluting stent for a chronic total occlusion 88.7% will have stent strut malapposition and 80.7% will have incomplete strut coverage on follow-up
Target lesion revascularization occurred in 39% of patients who underwent revascularization for a chronic total occlusion at 8 months